Production (Stage)
Cryo-Cell International, Inc.
CCEL
$4.83
$0.030.63%
AMEX
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.97M | 8.02M | 8.07M | 8.04M | 7.85M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.97M | 8.02M | 8.07M | 8.04M | 7.85M |
| Cost of Revenue | 1.98M | 1.64M | 2.13M | 2.02M | 2.07M |
| Gross Profit | 5.98M | 6.39M | 5.94M | 6.02M | 5.79M |
| SG&A Expenses | 4.64M | 6.01M | 4.15M | 4.02M | 4.43M |
| Depreciation & Amortization | 191.90K | 196.00K | 194.60K | 59.80K | 33.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.91M | 8.15M | 6.66M | 6.35M | 7.03M |
| Operating Income | 1.06M | -123.40K | 1.40M | 1.70M | 821.20K |
| Income Before Tax | 533.70K | -842.40K | 1.38M | 1.47M | 794.50K |
| Income Tax Expenses | 250.90K | 1.02M | 328.20K | 816.40K | 238.30K |
| Earnings from Continuing Operations | 282.90K | -1.86M | 1.05M | 655.80K | 556.20K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 282.90K | -1.86M | 1.05M | 655.80K | 556.20K |
| EBIT | 1.06M | -123.40K | 1.40M | 1.70M | 821.20K |
| EBITDA | 1.30M | 125.60K | 1.65M | 1.81M | 907.30K |
| EPS Basic | 0.04 | -0.23 | 0.13 | 0.08 | 0.07 |
| Normalized Basic EPS | 0.04 | -0.07 | 0.07 | 0.12 | 0.04 |
| EPS Diluted | 0.03 | -0.23 | 0.13 | 0.08 | 0.07 |
| Normalized Diluted EPS | 0.04 | -0.07 | 0.07 | 0.12 | 0.04 |
| Average Basic Shares Outstanding | 8.08M | 8.07M | 8.06M | 8.12M | 8.28M |
| Average Diluted Shares Outstanding | 8.20M | 8.07M | 8.17M | 8.23M | 8.33M |
| Dividend Per Share | 0.25 | 0.25 | -- | -- | -- |
| Payout Ratio | 714.34% | -108.54% | -- | -- | -- |